News
- News Post
Kaye Expands Presence in Sri Lanka Through Strategic Partnership with Synergy Bio
Kaye is pleased to announce a strategic partnership with Synergy Bio (Pvt) Ltd, a leading scientific solutions provider serving laboratories, manufacturers, and research institutions across Sri Lanka. This collaboration strengthens Kaye’s commitment to supporting the country’s growing life sciences industry with advanced thermal validation, environmental monitoring, and calibration technologies.
- Blog Post
Temperature Mapping in GxP Environments: How to Achieve Validation and Regulatory Compliance
Temperature-controlled environments are often assumed to operate uniformly, yet in practice, significant variations can exist within the same system. In pharmaceutical and biotechnology operations, even minor deviations can directly impact product stability, safety, and efficacy. This makes temperature mapping a critical requirement in pharmaceutical and biotech validation, cold chain management, and regulated storage environments.
- Blog Post
Get Ahead of Peak Heat: Summer Warehouse Mapping for Pharmaceutical Storage Stability
Summer introduces a predictable but often underestimated risk across pharmaceutical and life sciences supply chains. Elevated ambient temperatures, fluctuating humidity, and increased HVAC load can destabilize controlled environments. In such conditions, summer warehouse mapping becomes a critical validation activity rather than a routine exercise. A well-executed temperature mapping study goes beyond confirming storage conditions. It identifies systemic weaknesses, supports regulatory compliance, and enables data-driven environmental control strategies. When paired with a robust environmental monitoring system, it forms the backbone of continuous facility assurance.
- Blog Post
Are You Responsible for the Calibration of Temperature Sensors in a GxP Environment?
If calibration sits on your scope of responsibility, you already know it rarely stays a simple, routine task. In a GxP environment, calibration quickly becomes a question of data integrity, audit readiness, and ultimately, product quality. At first glance, verifying a temperature sensor may seem procedural. In practice, it carries far more weight. Every recorded value feeds into validation decisions, batch release, and compliance evidence. When that data is questioned, the impact extends far beyond a single instrument.
- News Post
INTERPHEX 2026 — Kaye’s Innovations in Validation, Monitoring, and Pharma 5.0
INTERPHEX 2026 delivered a dynamic three days of innovation and collaboration at the Javits Center in New York City (April 21–23, 2026). The event featured 600+ exhibitors, 100+ educational sessions, a record volume of equipment on display, and the debut of the Contract & Outsourcing Exchange (COEX), which hosted nearly 300 one‑to‑one partnering meetings. With an expanded show floor and strong increases in both attendee and supplier participation, INTERPHEX provided an exceptional forum for connecting, learning, and advancing pharmaceutical and biotech manufacturing.
- Blog Post
What Is Stability Chamber Validation? Key Components Explained
In pharmaceutical and biotech manufacturing, product stability is not an assumption. It is a documented outcome backed by controlled testing, verified data, and regulatory alignments, recreating defined environmental conditions to evaluate how products behave over time. However, the chamber itself must first be proven reliable. A quality system component whose performance must be proven, documented, and defended.
- Blog Post
AFNOR FDX15-140: Why correct mapping and validation of test chambers are now a quality and compliance requirement
AFNOR FDX15‑140 is a reference guideline for characterization, verification and ongoing surveillance of thermostatic and climatic enclosures (temperature ± humidity) such as chambers, ovens, incubators and cold/heat rooms at atmospheric pressure. The current version was published in August 2024 and is now in force; the previous version was published in May 2013 and has been withdrawn. The 2024 revision is not merely editorial — it brings measurable technical, metrological and operational changes and aligns the guidance more closely with ISO/IEC 17025 and IEC guidance.
- News Post
Kaye Launches ValProbe® RM: Next-Generation Wireless Monitoring for Pharma 5.0 Environments
Kaye announces the launch of the ValProbe® RM (Real-Time Monitoring) system, a new addition to its portfolio of validation and environmental monitoring solutions. Designed for pharmaceutical and biotechnology environments, the system introduces advanced wireless monitoring capabilities aligned with the evolving demands of Pharma 5.0 and data-driven compliance.
- News Post
Kaye at INTERPHEX 2026: Driving the Future of Validation and Monitoring
Kaye is set to participate in INTERPHEX 2026, taking place in New York City from April 21 to 23. Recognized as a leading global pharmaceutical and biotechnology event, INTERPHEX brings together innovation, expert-led education, and solution providers across the entire product lifecycle, from development through distribution.
- Blog Post
Who Still Remembers EN 554? Looking Back at the Transition to ISO 17665
Hard to believe, but in 2026 it has already been about two decades since EN 554:1994 was formally superseded. For many professionals working in sterilization validation today, the standard belongs to another era. Yet during conversations with validation engineers, quality specialists, and autoclave users, traces of EN 554 still appear in everyday practice.